Search tips
Search criteria 


Logo of jvirolPermissionsJournals.ASM.orgJournalJV ArticleJournal InfoAuthorsReviewers
J Virol. 2009 December; 83(24): 13037–13041.
Published online 2009 October 7. doi:  10.1128/JVI.01445-09
PMCID: PMC2786825

Effects of Acute and Chronic Murine Norovirus Infections on Immune Responses and Recovery from Friend Retrovirus Infection[down-pointing small open triangle]


Murine norovirus (MNV) is a highly infectious but generally nonpathogenic agent that is commonly found in research mouse colonies in both North America and Europe. In the present study, the effects of acute and chronic infections with MNV on immune responses and recovery from concurrent Friend virus (FV) infections were investigated. No significant differences in T-cell or NK-cell responses, FV-neutralizing antibody responses, or long-term recovery from FV infection were observed. We conclude that concurrent MNV infections had no major impacts on FV infections.

Murine noroviruses (MNV) are small single-stranded RNA viruses related to human noroviruses, which are the major cause of nonbacterial gastroenteritis in humans. Noroviruses are highly contagious and spread through the fecal-oral route. Although MNV generally does not cause overt clinical signs in immunocompetent mice, its high prevalence of 32% in North American and European research colonies (15, 23) raises the concern that coinfection with MNV might significantly impact studies being done on other pathogens. In this regard, MNV was recently shown to affect disease progression in bacterium-induced inflammatory bowel disease (19). However, another recent study showed no major impact of MNV on adaptive immunity to coinfection with either vaccinia virus or influenza A virus (14).

Several MNV strains have been described, some of which persist indefinitely and could potentially cause long-term consequences. It has previously been shown that either acute or chronic infection of mice with lactate dehydrogenase-elevating virus suppresses immune responses to coinfection with Friend virus (FV), a mouse retrovirus used by several research groups to study host-virus interactions (20, 25). Thus, there was a precedent for concern over the presence of intercurrent infections in FV studies. MNV replicates predominantly in gut enterocytes but also in antigen-presenting cells (APCs) such as macrophages and dendritic cells (29, 31). MNV infection of APCs could produce downstream effects on FV-specific immune responses that could significantly alter recovery.

FV is a retroviral complex consisting of replication-competent Friend murine leukemia virus and a pathogenic but replication-defective virus known as spleen focus-forming virus. Spleen focus-forming virus encodes a defective env protein (gp55) that binds to erythropoietin receptors on erythroid progenitors, causing them to proliferate, resulting in high numbers of erythroid blasts in hematopoietic tissues such as the spleen. Unless controlled by immune responses, FV infection leads to lethal erythroleukemia in most strains of mice and produces long-term, low-level chronic infections in mice that recover from acute infection (13). Recovery from acute FV infection is highly dependent on both T-cell (11, 24) and virus-neutralizing antibody responses (3, 12, 21), and the quality of these responses is dependent on host genes such as major histocompatibility complex genes (2). To determine whether MNV coinfection affects FV-specific immune responses and ultimately recovery from FV infection, we chose medium-recovery (B10.A × A.BY)F1 mice bearing one susceptible major histocompatibility complex haplotype (H-2a) and one resistant haplotype (H-2b) (2). These mice have detectable, but not optimal, immune responses, thus providing a sensitive model to detect either increased or decreased immune responses due to MNV coinfection.

Acute FV infection induces splenomegaly accompanied by significant alterations in cell subset proportions in the spleen (25), so it was important to determine whether MNV infection alone causes disruptions that might confound data from MNV-FV coinfections. Mice were infected orally with 30 μl of MNV-CR6 p5 containing 3 × 107 PFU. This strain of MNV persists long term (14, 28). MNV shedding was detected by reverse transcription-PCR as previously described (5), except that the starting material was a fresh pellet of mouse feces dissolved by shaking in 0.5 ml phosphate-buffered saline, and RNA was purified with the MagMAX-96 kit from Applied Biosystems. The open reading frame encoding helicase/protease/polymerase was targeted with the forward primer sequence (5′ to 3′) AATCTATGCGCCTGGTTTGC, the reverse primer sequence CTCATCACCCGGGCTGTT, and the probe sequence CACGCCACTCCGC.

Of 20 mice tested for chronic virus shedding, 19 tested positive at 4 to 6 weeks postinfection (wpi). There were no false positives in any of the 13 uninfected controls (data not shown). All mice in the experiment were housed in microisolator cages in the same room, and aseptic husbandry techniques were used to prevent cross contamination. No spread of MNV to mice in uninfected cages was observed over the course of the experiments.

Spleen cells were examined by flow cytometry during both the acute (1 wpi) and chronic (8 wpi) phases of MNV infection as previously described (25). At 1 wpi, there was a slight but statistically significant increase in the percentage of CD11b+ cells (predominantly monocytes and neutrophils) in the spleen, but the difference was no longer significant at 8 wpi (Fig. (Fig.1A).1A). No other significant changes in splenic cell subset proportions were observed in response to MNV infection (Fig. 1A and B).

FIG. 1.
Effect of MNV infection on splenic subset proportions. Mononuclear splenocytes from mice infected with MNV at 1 and 8 wpi were stained for (A) CD11b (macrophages), CD11c (dendritic cells), NK1.1 (NK cells), and Ter119 (erythroid progenitor cells) and ...

Splenic CD4+ and CD8+ T cells were analyzed for expression of the activation-induced isoform of CD43. CD43 is a cell surface molecule expressed on effector T cells but not on naïve or memory T cells (10). Interestingly, T cells examined at 1, 2, and 8 wpi showed no activation by MNV alone (Fig. 2A and D). For coinfection studies, the mice were also infected with approximately 2,000 spleen focus-forming units of B-tropic FV complex as described previously (25). FV infections were done either coincidently with MNV (acute MNV) or at 4 wpi with MNV (chronic MNV). The presence of either acute or chronic MNV infection did not significantly alter FV-induced activation of CD4+ T cells (Fig. (Fig.2A)2A) or CD8+ T cells (Fig. (Fig.2D).2D). Two functions important for the control of FV infections were examined, gamma interferon (IFN-γ) production by CD4+ T cells (18) and granzyme B production by CD8+ T cells (32, 34). There was no significant effect of MNV coinfection on the number of CD4+ T cells producing IFN-γ (Fig. (Fig.2B)2B) or the number of CD8+ T cells producing granzyme B (Fig. (Fig.2E).2E). CD8+ T cells were also analyzed with tetramers specific for an immunodominant FV epitope (1, 27). By 1 wpi, tetramer-positive CD8+ T cells expanded slightly in all groups infected with FV (P < 0.05) and reached levels of around five million per spleen by 2 wpi (Fig. (Fig.2F).2F). The levels of expansion were variable from mouse to mouse, but no significant differences between FV-infected groups at any time point were observed.

FIG. 2.
Cellular activation and function during FV-MNV coinfection. Splenocyte subsets were stained as indicated for activation markers (A, D, and G), IFN-γ (B), granzyme B (E), tetramer reactivity (F), and the regulatory T-cell marker Foxp3 (C). Data ...

A hallmark of FV infection is the induction of CD4+ regulatory T cells (Tregs) (6, 17) with significant expansion at 2 wpi (22, 33). CD4+ FoxP3+ Tregs were analyzed at 1, 2, and 8 wpi, with expansion most evident at 2 wpi (Fig. (Fig.2C).2C). Unlike FV infection, MNV infection by itself did not induce expansion of Tregs in the spleen. Again, MNV coinfections did not significantly alter the numbers of Tregs between groups of mice infected with FV. Natural killer (NK) cells also play a protective role in FV infections (16), and a significant proportion of splenic NK cells (NK1.1+) were activated in response to FV infection at all three time points (Fig. (Fig.2G).2G). In contrast, there was no evidence of NK-cell activation in response to MNV only, and concurrent MNV infection did not significantly affect the NK response to FV infection at any of the time points.

Acute FV infection of (B10.A × A.BY)F1 mice produces high levels of plasma viremia that are controlled by virus-neutralizing antibody responses (7, 26). At 1 wpi, all mice had very high viremia levels (Fig. (Fig.3A)3A) with no detectable virus-neutralizing antibody responses (Fig. (Fig.3B).3B). By 2 wpi, virus-neutralizing antibody responses were detectable and viremia was cleared in almost all of the mice. There were no significant differences between the groups, indicating that MNV coinfection did not alter either the antibody responses or viremia levels.

FIG. 3.
Viremia and virus-neutralizing antibody titers. (A) Mean plasma viremia titers (± the standard deviations; n = 4 per group for each time point) and (B) virus-neutralizing antibody titers were determined as previously described (21). The ...

Levels of cellular infection in the spleen were analyzed by flow cytometry to detect expression of the FV-encoded glycosylated gag antigen (8, 9) and to measure the proliferation of erythroid precursors in the spleen. At 1 wpi, there was a high level of both viral antigen expression (monoclonal antibody 34+) and erythroid cell (Ter119+) proliferation in the spleen (Fig. 4A and B). By 2 wpi, FV infection was in decline. Although mice concurrently infected with MNV and FV appeared to have lower levels of FV antigen expression at 2 wpi, the difference was not statistically significant due to the high degree of mouse-to-mouse variability at this time point, when the antiviral immune response is becoming effective (Fig. (Fig.4A).4A). There were also no significant differences associated with MNV coinfection in levels of erythroid cell proliferation or in levels of spleen cells producing live virus, as measured by infectious-center assays (Fig. (Fig.4C).4C). All of the mice in all of the groups that recovered from acute FV infection survived the infection for 8 weeks and had equivalent levels of chronic FV infection at 8 wpi (Fig. (Fig.4C).4C). Thus, there was no indication that MNV affected FV infection levels or recovery from infection.

FIG. 4.
Cell-associated FV titers and pathology. Bars indicate means and standard deviations. (A) Spleen cells were stained with monoclonal antibody (MAb) 34 to detect cell surface expression of the FV-encoded glycosylated gag antigen as described previously ...

It has been shown that prior infections with a number of viruses can skew the T-cell repertoire and thereby alter responses to subsequent infections in either beneficial or harmful ways (30). No evidence of such changes was observed in this study, but detailed analyses of the repertoire are required to rule out such effects. However, we can conclude that neither acute nor chronic MNV infection impacted FV-induced immune responses or recovery from FV infection in any major way. This conclusion is basically the same as that reached in studies on the effects of MNV on influenza and vaccinia virus infections (14) but different from that reached in studies on bacterium-induced inflammatory bowel disease, where significant effects were observed (19). A very preliminary conclusion from these results is that the effects of concurrent norovirus infection might be more likely to affect infections of the gastrointestinal tract than of other locations. In the present experiments, little evidence of a systemic immune response to MNV was observed in the spleen, suggesting that the response might be localized to gut-associated lymphatic tissues. It is also possible that the difference between bacterial and viral infections is an important one. It remains important to investigate each type of infection being studied and also to keep in mind that there are numerous strains of MNV (28), some of which might cause different effects. Thus, care must be taken not to generalize to other coinfecting viruses or to other norovirus strains.


We are very grateful to Herbert W. Virgin for sharing MNV stocks with us and providing important advice and criticism.

This work was supported by the Division of Intramural Research of the NIAID, NIH.


[down-pointing small open triangle]Published ahead of print on 7 October 2009.


1. Chen, W., H. Qin, B. Chesebro, and M. A. Cheever. 1996. Identification of a gag-encoded cytotoxic T-lymphocyte epitope from FBL-3 leukemia shared by Friend, Moloney, and Rauscher murine leukemia virus-induced tumors. J. Virol. 70:7773-7782. [PMC free article] [PubMed]
2. Chesebro, B., M. Miyazawa, and W. J. Britt. 1990. Host genetic control of spontaneous and induced immunity to Friend murine retrovirus infection. Annu. Rev. Immunol. 8:477-499. [PubMed]
3. Chesebro, B., and K. Wehrly. 1979. Identification of a non-H-2 gene (Rfv-3) influencing recovery from viremia and leukemia induced by Friend virus complex. Proc. Natl. Acad. Sci. USA 76:425-429. [PubMed]
4. Chesebro, B., K. Wehrly, K. Watson, and K. Chesebro. 1978. Murine leukemia virus infectious centers are dependent on the rate of virus production by infected cells. Virology 84:222-226. [PubMed]
5. Dimcheff, D. E., S. Askovic, A. H. Baker, C. Johnson-Fowler, and J. L. Portis. 2003. Endoplasmic reticulum stress is a determinant of retrovirus-induced spongiform neurodegeneration. J. Virol. 77:12617-12629. [PMC free article] [PubMed]
6. Dittmer, U., H. He, R. J. Messer, S. Schimmer, A. R. Olbrich, C. Ohlen, P. D. Greenberg, I. M. Stromnes, M. Iwashiro, S. Sakaguchi, L. H. Evans, K. E. Peterson, G. Yang, and K. J. Hasenkrug. 2004. Functional impairment of CD8+ T cells by regulatory T cells during persistent retroviral infection. Immunity 20:293-303. [PubMed]
7. Doig, D., and B. Chesebro. 1979. Anti-Friend virus antibody is associated with recovery from viremia and loss of viral leukemia cell-surface antigens in leukemic mice. Identification of Rfv-3 as a gene locus influencing antibody production. J. Exp. Med. 150:10-19. [PMC free article] [PubMed]
8. Edwards, S. A., and H. Fan. 1979. gag-related polyproteins of Moloney murine leukemia virus: evidence for independent synthesis of glycosylated and unglycosylated forms. J. Virol. 30:551-563. [PMC free article] [PubMed]
9. Evans, L. H., S. Dresler, and D. Kabat. 1977. Synthesis and glycosylation of polyprotein precursors to the internal core proteins of Friend murine leukemia virus. J. Virol. 24:865-874. [PMC free article] [PubMed]
10. Harrington, L. E., M. Galvan, L. G. Baum, J. D. Altman, and R. Ahmed. 2000. Differentiating between memory and effector CD8 T cells by altered expression of cell surface O-glycans. J. Exp. Med. 191:1241-1246. [PMC free article] [PubMed]
11. Hasenkrug, K. J. 1999. Lymphocyte deficiencies increase susceptibility to Friend virus-induced erythroleukemia in Fv-2 genetically resistant mice. J. Virol. 73:6468-6473. [PMC free article] [PubMed]
12. Hasenkrug, K. J., D. M. Brooks, and B. Chesebro. 1995. Passive immunotherapy for retroviral disease: influence of major histocompatibility complex type and T-cell responsiveness. Proc. Natl. Acad. Sci. USA 92:10492-10495. [PubMed]
13. Hasenkrug, K. J., and U. Dittmer. 2007. Immune control and prevention of chronic Friend retrovirus infection. Front. Biosci. 12:1544-1551. [PubMed]
14. Hensley, S. E., A. K. Pinto, H. D. Hickman, R. J. Kastenmayer, J. R. Bennink, H. W. Virgin, and J. W. Yewdell. 2009. Murine norovirus infection has no significant effect on adaptive immunity to vaccinia virus or influenza A virus. J. Virol. 83:7357-7360. [PMC free article] [PubMed]
15. Hsu, C. C., C. E. Wobus, E. K. Steffen, L. K. Riley, and R. S. Livingston. 2005. Development of a microsphere-based serologic multiplexed fluorescent immunoassay and a reverse transcriptase PCR assay to detect murine norovirus 1 infection in mice. Clin. Diagn. Lab. Immunol. 12:1145-1151. [PMC free article] [PubMed]
16. Iwanami, N., A. Niwa, Y. Yasutomi, N. Tabata, and M. Miyazawa. 2001. Role of natural killer cells in resistance against Friend retrovirus-induced leukemia. J. Virol. 75:3152-3163. [PMC free article] [PubMed]
17. Iwashiro, M., R. J. Messer, K. E. Peterson, I. M. Stromnes, T. Sugie, and K. J. Hasenkrug. 2001. Immunosuppression by CD4+ regulatory T cells induced by chronic retroviral infection. Proc. Natl. Acad. Sci. USA 98:9226-9230. [PubMed]
18. Iwashiro, M., K. Peterson, R. J. Messer, I. M. Stromnes, and K. J. Hasenkrug. 2001. CD4+ T cells and gamma interferon in the long-term control of persistent Friend retrovirus infection. J. Virol. 75:52-60. [PMC free article] [PubMed]
19. Lencioni, K. C., A. Seamons, P. M. Treuting, L. Maggio-Price, and T. Brabb. 2008. Murine norovirus: an intercurrent variable in a mouse model of bacteria-induced inflammatory bowel disease. Comp. Med. 58:522-533. [PubMed]
20. Marques, R., I. Antunes, U. Eksmond, J. Stoye, K. Hasenkrug, and G. Kassiotis. 2008. B lymphocyte activation by coinfection prevents immune control of Friend virus infection. J. Immunol. 181:3432-3440. [PMC free article] [PubMed]
21. Messer, R. J., U. Dittmer, K. E. Peterson, and K. J. Hasenkrug. 2004. Essential role for virus-neutralizing antibodies in sterilizing immunity against Friend retrovirus infection. Proc. Natl. Acad. Sci. USA 101:12260-12265. [PubMed]
22. Myers, L., R. J. Messer, A. B. Carmody, and K. J. Hasenkrug. 2009. Tissue specific abundance of regulatory T cells correlates with CD8+ T cell dysfunction and chronic retrovirus loads. J. Immunol. 183:1636-1643. [PMC free article] [PubMed]
23. Pritchett-Corning, K. R., J. Cosentino, and C. B. Clifford. 2009. Contemporary prevalence of infectious agents in laboratory mice and rats. Lab. Anim. 43:165-173. [PubMed]
24. Robertson, M. N., G. J. Spangrude, K. Hasenkrug, L. Perry, J. Nishio, K. Wehrly, and B. Chesebro. 1992. Role and specificity of T-cell subsets in spontaneous recovery from Friend virus-induced leukemia in mice. J. Virol. 66:3271-3277. [PMC free article] [PubMed]
25. Robertson, S. J., C. G. Ammann, R. J. Messer, A. B. Carmody, L. Myers, U. Dittmer, S. Nair, N. Gerlach, L. H. Evans, W. A. Cafruny, and K. J. Hasenkrug. 2008. Suppression of acute anti-Friend virus CD8+ T-cell responses by coinfection with lactate dehydrogenase-elevating virus. J. Virol. 82:408-418. [PMC free article] [PubMed]
26. Santiago, M. L., M. Montano, R. Benitez, R. J. Messer, W. Yonemoto, B. Chesebro, K. J. Hasenkrug, and W. C. Greene. 2008. Apobec3 encodes Rfv3, a gene influencing neutralizing antibody control of retrovirus infection. Science 321:1343-1346. [PMC free article] [PubMed]
27. Schepers, K., M. Toebes, G. Sotthewes, F. A. Vyth-Dreese, T. A. Dellemijn, C. J. Melief, F. Ossendorp, and T. N. Schumacher. 2002. Differential kinetics of antigen-specific CD4+ and CD8+ T cell responses in the regression of retrovirus-induced sarcomas. J. Immunol. 169:3191-3199. [PubMed]
28. Thackray, L. B., C. E. Wobus, K. A. Chachu, B. Liu, E. R. Alegre, K. S. Henderson, S. T. Kelley, and H. W. Virgin. 2007. Murine noroviruses comprising a single genogroup exhibit biological diversity despite limited sequence divergence. J. Virol. 81:10460-10473. [PMC free article] [PubMed]
29. Virgin, H. W. 2005. Immune regulation of viral infection and vice versa. Immunol. Res. 32:293-315. [PubMed]
30. Welsh, R. M., S. K. Kim, M. Cornberg, S. C. Clute, L. K. Selin, and Y. N. Naumov. 2006. The privacy of T cell memory to viruses. Curr. Top. Microbiol. Immunol. 311:117-153. [PubMed]
31. Wobus, C. E., S. M. Karst, L. B. Thackray, K. O. Chang, S. V. Sosnovtsev, G. Belliot, A. Krug, J. M. Mackenzie, K. Y. Green, and H. W. Virgin. 2004. Replication of norovirus in cell culture reveals a tropism for dendritic cells and macrophages. PLoS Biol. 2:e432. [PMC free article] [PubMed]
32. Zelinskyy, G., S. Balkow, S. Schimmer, K. Schepers, M. M. Simon, and U. Dittmer. 2004. Independent roles of perforin, granzymes, and Fas in the control of Friend retrovirus infection. Virology 330:365-374. [PubMed]
33. Zelinskyy, G., A. R. Kraft, S. Schimmer, T. Arndt, and U. Dittmer. 2006. Kinetics of CD8+ effector T cell responses and induced CD4+ regulatory T cell responses during Friend retrovirus infection. Eur. J. Immunol. 36:2658-2670. [PubMed]
34. Zelinskyy, G., S. J. Robertson, S. Schimmer, R. J. Messer, K. J. Hasenkrug, and U. Dittmer. 2005. CD8+ T-cell dysfunction due to cytolytic granule deficiency in persistent Friend retrovirus infection. J. Virol. 79:10619-10626. [PMC free article] [PubMed]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)